File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Octreotide for treatment of postoperative chylothorax
  • Basic View
  • Metadata View
  • XML View
TitleOctreotide for treatment of postoperative chylothorax
 
AuthorsCheung, YF1
Leung, MP1
Yip, MM1
 
Issue Date2001
 
PublisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jpeds
 
CitationJournal Of Pediatrics, 2001, v. 139 n. 1, p. 157-159 [How to Cite?]
DOI: http://dx.doi.org/10.1067/mpd.2001.115572
 
AbstractTwo infants who developed chylothorax after surgery for congenital heart disease were treated successfully with subcutaneous octreotide. Apart from reducing chyle output, octreotide decreased the triglyceride content of the pleural fluid.
 
ISSN0022-3476
2013 Impact Factor: 3.736
 
DOIhttp://dx.doi.org/10.1067/mpd.2001.115572
 
ISI Accession Number IDWOS:000169877100033
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorCheung, YF
 
dc.contributor.authorLeung, MP
 
dc.contributor.authorYip, MM
 
dc.date.accessioned2012-10-30T06:07:24Z
 
dc.date.available2012-10-30T06:07:24Z
 
dc.date.issued2001
 
dc.description.abstractTwo infants who developed chylothorax after surgery for congenital heart disease were treated successfully with subcutaneous octreotide. Apart from reducing chyle output, octreotide decreased the triglyceride content of the pleural fluid.
 
dc.description.naturelink_to_subscribed_fulltext
 
dc.identifier.citationJournal Of Pediatrics, 2001, v. 139 n. 1, p. 157-159 [How to Cite?]
DOI: http://dx.doi.org/10.1067/mpd.2001.115572
 
dc.identifier.doihttp://dx.doi.org/10.1067/mpd.2001.115572
 
dc.identifier.epage159
 
dc.identifier.isiWOS:000169877100033
 
dc.identifier.issn0022-3476
2013 Impact Factor: 3.736
 
dc.identifier.issue1
 
dc.identifier.pmid11445812
 
dc.identifier.scopuseid_2-s2.0-0034969414
 
dc.identifier.spage157
 
dc.identifier.urihttp://hdl.handle.net/10722/170310
 
dc.identifier.volume139
 
dc.languageeng
 
dc.publisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jpeds
 
dc.publisher.placeUnited States
 
dc.relation.ispartofJournal of Pediatrics
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshChylothorax - Drug Therapy
 
dc.subject.meshFemale
 
dc.subject.meshHeart Defects, Congenital - Surgery
 
dc.subject.meshHormones - Administration & Dosage - Therapeutic Use
 
dc.subject.meshHumans
 
dc.subject.meshInfant
 
dc.subject.meshInjections, Subcutaneous
 
dc.subject.meshMale
 
dc.subject.meshOctreotide - Administration & Dosage - Therapeutic Use
 
dc.subject.meshPleural Effusion - Metabolism
 
dc.subject.meshPostoperative Complications - Drug Therapy
 
dc.titleOctreotide for treatment of postoperative chylothorax
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Cheung, YF</contributor.author>
<contributor.author>Leung, MP</contributor.author>
<contributor.author>Yip, MM</contributor.author>
<date.accessioned>2012-10-30T06:07:24Z</date.accessioned>
<date.available>2012-10-30T06:07:24Z</date.available>
<date.issued>2001</date.issued>
<identifier.citation>Journal Of Pediatrics, 2001, v. 139 n. 1, p. 157-159</identifier.citation>
<identifier.issn>0022-3476</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/170310</identifier.uri>
<description.abstract>Two infants who developed chylothorax after surgery for congenital heart disease were treated successfully with subcutaneous octreotide. Apart from reducing chyle output, octreotide decreased the triglyceride content of the pleural fluid.</description.abstract>
<language>eng</language>
<publisher>Mosby, Inc. The Journal&apos;s web site is located at http://www.elsevier.com/locate/jpeds</publisher>
<relation.ispartof>Journal of Pediatrics</relation.ispartof>
<subject.mesh>Chylothorax - Drug Therapy</subject.mesh>
<subject.mesh>Female</subject.mesh>
<subject.mesh>Heart Defects, Congenital - Surgery</subject.mesh>
<subject.mesh>Hormones - Administration &amp; Dosage - Therapeutic Use</subject.mesh>
<subject.mesh>Humans</subject.mesh>
<subject.mesh>Infant</subject.mesh>
<subject.mesh>Injections, Subcutaneous</subject.mesh>
<subject.mesh>Male</subject.mesh>
<subject.mesh>Octreotide - Administration &amp; Dosage - Therapeutic Use</subject.mesh>
<subject.mesh>Pleural Effusion - Metabolism</subject.mesh>
<subject.mesh>Postoperative Complications - Drug Therapy</subject.mesh>
<title>Octreotide for treatment of postoperative chylothorax</title>
<type>Article</type>
<description.nature>link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1067/mpd.2001.115572</identifier.doi>
<identifier.pmid>11445812</identifier.pmid>
<identifier.scopus>eid_2-s2.0-0034969414</identifier.scopus>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-0034969414&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>139</identifier.volume>
<identifier.issue>1</identifier.issue>
<identifier.spage>157</identifier.spage>
<identifier.epage>159</identifier.epage>
<identifier.isi>WOS:000169877100033</identifier.isi>
<publisher.place>United States</publisher.place>
</item>
Author Affiliations
  1. The University of Hong Kong